These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 20465120)

  • 1. [Is the metabolic syndrome still a useful entity?].
    Charbonnel B
    Rev Prat; 2010 Apr; 60(4):478-84. PubMed ID: 20465120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Metabolic syndrome and cardiovascular risk].
    Charbonnel B
    Rev Prat; 2005 Oct; 55(16):1765-71. PubMed ID: 16363426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic syndrome in Cushing's syndrome.
    Chanson P; Salenave S
    Neuroendocrinology; 2010; 92 Suppl 1():96-101. PubMed ID: 20829627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Body-mass index, abdominal adiposity, and cardiovascular risk.
    Gonçalves FB; Koek M; Verhagen HJ; Niessen WJ; Poldermans D
    Lancet; 2011 Jul; 378(9787):227; author reply 228. PubMed ID: 21763933
    [No Abstract]   [Full Text] [Related]  

  • 5. Hypertriglyceridemia is a practical biomarker of metabolic syndrome in individuals with abdominal obesity.
    Li Z; Deng ML; Tseng CH; Heber D
    Metab Syndr Relat Disord; 2013 Apr; 11(2):87-91. PubMed ID: 23259588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk.
    Després JP; Lemieux I; Bergeron J; Pibarot P; Mathieu P; Larose E; Rodés-Cabau J; Bertrand OF; Poirier P
    Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1039-49. PubMed ID: 18356555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Waist circumference and BMI cut-off points to predict risk factors for metabolic syndrome among outpatients in a district hospital.
    Aye M; Sazali M
    Singapore Med J; 2012 Aug; 53(8):545-50. PubMed ID: 22941134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Markers of visceral obesity and cardiovascular risk in patients with polycystic ovarian syndrome.
    Gateva AT; Kamenov ZA
    Eur J Obstet Gynecol Reprod Biol; 2012 Oct; 164(2):161-6. PubMed ID: 22727921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abdominal obesity, insulin resistance, and the metabolic syndrome: contribution of physical activity/exercise.
    Ross R; Després JP
    Obesity (Silver Spring); 2009 Dec; 17 Suppl 3():S1-2. PubMed ID: 19927139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The metabolic syndrome: underdiagnosed and undertreated.
    Ripsin C
    South Med J; 2009 Dec; 102(12):1194-5. PubMed ID: 20016419
    [No Abstract]   [Full Text] [Related]  

  • 11. Metabolic syndrome, abdominal obesity, and cardiovascular risk in elderly women.
    Cabrera MA; Gebara OC; Diament J; Nussbacher A; Rosano G; Wajngarten M
    Int J Cardiol; 2007 Jan; 114(2):224-9. PubMed ID: 16784787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [From the metabolic syndrome to the concept of global cardiometabolic risk].
    Nádas J; Jermendy G
    Orv Hetil; 2009 May; 150(18):821-9. PubMed ID: 19383573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Waist:height ratio, waist circumference and metabolic syndrome abnormalities in Colombian schooled adolescents: a multivariate analysis considering located adiposity.
    Agredo-Zúñiga RA; Aguilar-de Plata C; Suárez-Ortegón MF
    Br J Nutr; 2015 Sep; 114(5):700-5. PubMed ID: 26279413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abdominal obesity and metabolic syndrome.
    Després JP; Lemieux I
    Nature; 2006 Dec; 444(7121):881-7. PubMed ID: 17167477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic syndrome in the prevention of cardiovascular diseases and diabetes--still a matter of debate?
    Ma X; Zhu S
    Eur J Clin Nutr; 2013 May; 67(5):518-21. PubMed ID: 23403882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic syndrome a widespread threatening condition; risk factors, diagnostic criteria, therapeutic options, prevention and controversies: an overview.
    Amihăesei IC; Chelaru L
    Rev Med Chir Soc Med Nat Iasi; 2014; 118(4):896-900. PubMed ID: 25581945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel component of the metabolic syndrome: the oxidative stress.
    Hopps E; Noto D; Caimi G; Averna MR
    Nutr Metab Cardiovasc Dis; 2010 Jan; 20(1):72-7. PubMed ID: 19747805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of different definitions of the metabolic syndrome on the prevalence of organ damage, cardiometabolic risk and cardiovascular events.
    Mancia G; Bombelli M; Facchetti R; Casati A; Ronchi I; Quarti-Trevano F; Arenare F; Grassi G; Sega R
    J Hypertens; 2010 May; 28(5):999-1006. PubMed ID: 20308922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The concept of cardiometabolic risk: Bridging the fields of diabetology and cardiology.
    Després JP; Cartier A; Côté M; Arsenault BJ
    Ann Med; 2008; 40(7):514-23. PubMed ID: 18608131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central obesity, the metabolic syndrome, and plasminogen activator inhibitor-1 in young adults.
    Appel SJ; Harrell JS; Davenport ML
    J Am Acad Nurse Pract; 2005 Dec; 17(12):535-41. PubMed ID: 16293162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.